09RS HB297
LRC Seal

HB297

09RS

WWW Version

The hyperlink to a bill draft that precedes a summary contains the most recent version (Introduced/GA/Enacted) of the bill. If the session has ended, the hyperlink contains the latest version of the bill at the time of sine die adjournment. Note that the summary pertains to the bill as introduced, which is often different from the most recent version.

Includes opposite chamber sponsors where requested by primary sponsors of substantially similar bills in both chambers and jointly approved by the Committee on Committees of both chambers. Opposite chamber sponsors are represented in italics.


HB 297 (BR 1250) - T. Burch

     AN ACT relating to pharmacists.
     Amend KRS 217.215 to allow a pharmacist to dispense up to a 30-day supply of a maintenance drug in emergency situations; amend KRS 315.010 to redefine collaborative care agreement to include multiple practitioners and multiple patients; create new sections of KRS Chapter 315 to define enhanced pharmacy-related primary care as additional acts by trained pharmacists certified by the Board of Pharmacy to provide enhanced pharmacy-related primary care including authority to issue nonscheduled legend drugs; require the board to establish an enhanced pharmacy-related primary care advisory committee, specify membership; require administrative regulations to specify scope of practice, diseases and conditions that may be treated, approval of course of study and clinical experience required for certification, and terms of a collaborative agreement; amend KRS 217.015 to include a pharmacist certified to provide enhanced pharmacy-related primary care as a practitioner.

HB 297 - AMENDMENTS


     HCS - Replace existing language to direct LRC staff to study the scope of practice for pharmacists and reasons for and against expanding the scope of practice of pharmacists to allow more flexibility in treating chronic health care conditions and drug-related primary care through collaboration with physicians.

     HFA (1, J. Fischer) - Delete original provisions of the bill; amend KRS 311.720 to include the use of abortifacients, including Mifepristone, in the definition of "abortion"; amend KRS 311.732 to include Mifepristone in the definition of "abortion"; and create a new section of KRS Chapter 315 to prohibit a pharmacist who objects to dispensing medication or devices that may terminate a pregnancy from liability; prohibit discrimination against a pharmacist who objects to dispensing medication that may terminate a pregnancy.

     HFA (2, J. Fischer) - Retain provisions of HB 297/HCS; amend KRS 311.720 to include the use of abortifacients, including Mifepristone, in the definition of "abortion"; amend KRS 311.732 to include Mifepristone in the definition of "abortion"; and create a new section of KRS Chapter 315 to prohibit a pharmacist who objects to dispensing medication or devices that may terminate a pregnancy from liability; prohibit discrimination against a pharmacist who objects to dispensing medication that may terminate a pregnancy.

     Feb 5-introduced in House
     Feb 6-to Health & Welfare (H)
     Feb 12-posted in committee
     Feb 26-reported favorably, 1st reading, to Calendar with Committee Substitute
     Feb 27-2nd reading, to Rules
     Mar 2-posted for passage in the Regular Orders of the Day for Tuesday, March 3, 2009; taken from the Regular Orders of the Day; recommitted to Health & Welfare (H); floor amendment (2) filed to Committee Substitute, floor amendment (1) filed to bill


Legislature Home Page | Record Front Page